Cell Microsystems Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
2ndary - Private
- Investors
-
8
Cell Microsystems General Information
Description
Developer of a biological tool designed for single-cell research. The company's tools can sort and isolate single cells using the array line of consumables under standard culture conditions, resulting in unperturbed phenotypes and high viability, enabling scientists to select a cell in real-time and track and trace that cell through imaging, collection, and downstream analysis, as well as end-point destructive analysis of single cells for genomics.
Contact Information
Website
www.cellmicrosystems.comCorporate Office
- 801 Capitola Drive
- Suite 10
- Durham, NC 27713
- United States
Corporate Office
- 801 Capitola Drive
- Suite 10
- Durham, NC 27713
- United States
Cell Microsystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 16. Later Stage VC (Series B) | 28-Aug-2023 | Completed | Generating Revenue | |||
| 15. Later Stage VC (Series A) | 15-Nov-2021 | Completed | Generating Revenue | |||
| 14. Grant | 01-Aug-2021 | Completed | Generating Revenue | |||
| 13. Debt - PPP | 27-Jan-2021 | Completed | Generating Revenue | |||
| 12. Grant | 22-Jan-2021 | Completed | Generating Revenue | |||
| 11. Debt - General | 07-Oct-2020 | Completed | Generating Revenue | |||
| 10. Grant | 01-Aug-2020 | Completed | Generating Revenue | |||
| 9. Debt - PPP | 15-Apr-2020 | $281K | $250K | Completed | Generating Revenue | |
| 8. Accelerator/Incubator | 05-Oct-2019 | $250K | Completed | Generating Revenue |
Cell Microsystems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cell Microsystems Comparisons
Industry
Financing
Details
Cell Microsystems Competitors (22)
One of Cell Microsystems’s 22 competitors is Parse Biosciences, a Formerly VC-backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Parse Biosciences | Formerly VC-backed | Seattle, WA | ||||
| Genuity Science | Formerly VC-backed | Dublin, Ireland | ||||
| Nanion Technologies | Accelerator/Incubator Backed | Munich, Germany | ||||
| Molecular Devices | Corporate Backed or Acquired | San Jose, CA | ||||
| Mission Bio | Venture Capital-Backed | San Francisco, CA |
Cell Microsystems Patents
Cell Microsystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2024532375-A | An automated system for imaging, identification, and isolation of organoids | Pending | 27-Aug-2021 | ||
| CA-3230050-A1 | Automated system for imaging, identification, and isolation of organoids | Pending | 27-Aug-2021 | ||
| EP-4392538-A2 | Automated system for imaging, identification, and isolation of organoids | Inactive | 27-Aug-2021 | ||
| EP-4392538-A4 | Automated system for imaging, identification, and isolation of organoids | Inactive | 27-Aug-2021 | ||
| US-12770416-B2 | Automated system for imaging, identification, and isolation of organoids | Active | 27-Aug-2021 | G06V20/698 |
Cell Microsystems Signals
Cell Microsystems Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Telegraph Hill Partners | Venture Capital | Minority | ||
| First Flight Venture Center | Accelerator/Incubator | |||
| National Cancer Institute | Government | |||
| The National Human Genome Research Institute | Government | |||
| National Institute for Allergy and Infectious Disease | Government |
Cell Microsystems Acquisitions (1)
Cell Microsystems’s most recent deal was a Merger/Acquisition with Fluxion (Diagnostic Equipment). The deal was made on 23-Aug-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Fluxion (Diagnostic Equipment) | 23-Aug-2023 | Merger/Acquisition | Diagnostic Equipment |
Cell Microsystems Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Fluxion (Diagnostic Equipment) | Alameda, CA | 2005 |
Cell Microsystems FAQs
-
When was Cell Microsystems founded?
Cell Microsystems was founded in 2010.
-
Where is Cell Microsystems headquartered?
Cell Microsystems is headquartered in Durham, NC.
-
What is the size of Cell Microsystems?
Cell Microsystems has 22 total employees.
-
What industry is Cell Microsystems in?
Cell Microsystems’s primary industry is Discovery Tools (Healthcare).
-
Is Cell Microsystems a private or public company?
Cell Microsystems is a Private company.
-
What is Cell Microsystems’s current revenue?
The current revenue for Cell Microsystems is .
-
How much funding has Cell Microsystems raised over time?
Cell Microsystems has raised $19.7M.
-
Who are Cell Microsystems’s investors?
Telegraph Hill Partners, First Flight Venture Center, National Cancer Institute, The National Human Genome Research Institute, and National Institute for Allergy and Infectious Disease are 5 of 8 investors who have invested in Cell Microsystems.
-
Who are Cell Microsystems’s competitors?
Parse Biosciences, Genuity Science, Nanion Technologies, Molecular Devices, and Mission Bio are some of the 22 competitors of Cell Microsystems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process